Leading AI search tools give unreliable answers about home blood pressure monitor validation, research finds
Three of four leading artificial intelligence (AI) search tools accurately identified home blood pressure monitors that met validated clinical standards only 63–83% of the time, according to preliminary research being presented at the American Heart Association's Hypertension Scientific Sessions 2026, held in Arlington, Virginia, Oct. 7–11.
A study presented at the American Heart Association's Hypertension Scientific Sessions 2026 found that four leading AI search tools only accurately identified home blood pressure monitors that met validated clinical standards about 63-83% of the time. High blood pressure affects more than 125 million adults in the U.S. and is the primary risk factor for cardiovascular disease.
The 2025 American Heart Association Guideline recommends using validated home blood pressure monitoring devices, which are confirmed through independent, third-party testing. However, AI-powered chatbots, including Google Gemini, often failed to reliably determine if a device had been validated. The researchers tested a wide range of devices, including lesser-known ones, and the AI tools struggled to interpret being listed on official registries as proof of validation.
This discrepancy highlights the need for caution when relying on AI for clinical decision-making, as well as the importance of using official registries to verify the validation status of home blood pressure devices.
Rewritten by urgent.news; may contain errors — check the original.
Source: medicalxpress.com